GGS
CAH icon

Galvin Gaustad & Stein’s Cardinal Health CAH Stock Holding History

Galvin Gaustad & Stein’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,228
Closed -$249K – 185
2024
Q1 		$249K Sell
2,228
-191
-8% -$20.6K 0.02% 161
2023
Q4 		$244K Buy
+2,419
New +$240K 0.02% 166

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Galvin Gaustad & Stein's CAH Position: Q2 2024 in Review

Galvin Gaustad & Stein sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 2,228 shares — an estimated $249K sold.

Galvin Gaustad & Stein first reported a position in CAH in Q4 2023 and held it in 2 quarters. The position peaked at $249K in Q1 2024. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Galvin Gaustad & Stein reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • Galvin Gaustad & Stein sold 2,228 Cardinal Health shares in Q2 2024, an estimated $249K.
  • Galvin Gaustad & Stein first reported a position in Cardinal Health in Q4 2023 and held it in 2 quarters.
  • Galvin Gaustad & Stein's Cardinal Health position peaked at $249K in Q1 2024.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Galvin Gaustad & Stein's 13F filing for Q2 2024, filed 17 Jul 2024.